Get started

GTEC

Trulieve - Bears are in controlDear Traders, Trulieve enjoyed a small 4% run after it broke out of the triangle, after this a lot of selling pressure occurred, as this stock is quite new on the market, we can't tell much yet. For example, there is still no 55 ema showing, no 100 ema and also no 200ema. Once these indicators will show up we will be abel to tell more about trulieve price action and most importantly, trulieve's future! Any thoughts? Feel free to join my new Discord Channel if you interested in talking to me and others about stocks, info and of course opportunities! discord.gg Thanks !
OTC:TCNNFShort
by Raw_Blitz
TGOD - Going Bullish Soon ?Dear Traders, For those who entered TGOD at 3-5 C$ I hope you could enjoy some great profits from this stock. I was so thrilled to see it go down as it did. Finally, we reached the Buy Zone! Traders are jumping in creating more Volume compared to previous days, and TGOD is now attacking the 100 ema, and after that the 200 ema ! Those lines are the resistance points we need to keep an eye on if we enter a trade here. Right now TGOD's bulls are trying to breach the 55 ema, which could happen soon. So, what are you thoughts ? Time to buy ? Wait for lower price ? Feel free to join my new Discord Channel if you interested in talking to me and others about stocks, info and of course opportunities! discord.gg Thanks !
TLong
by Raw_Blitz
13
Aurora Cannabis - What Now ?Dear Traders, Yesterday was a pretty weird day for ACB, we expected a run, we got one, but it wasn't as powerful as we hopped. I new All Time High (ATH) got created tho, but the question is, is there more to come Reviewing the Chart I decided to trace some lines to see where wee are at. As we all can see Our RSI is still above 50 but for how long ? Our MACD isn't ready to cross upwards yet so this makes me feel like this price is going down more. Towards the 55 ema (blue line). If the bulls manage to open with a nice bump it would do some good to this chart, but if we open with a downtrend, that 55 ema is imminent. I personally enterred a position yesterday hoping the bulls would create a run-up last minute but that didn't happen and my stoploss is set but not hit yet. Let's see how this plays-off today! If the 55 ema get's hit, do make sure to look at what the MACD is doing and where the RSI is at before making an entry. We are now inside a bearish channel and the only way the price will go up is if the bulls manage to breakout of it. For now i'm Neutral regarding Aurora but with some luck and some good volume, we could see something good coming out of this, but that ain't certain at all. My opinion? stay out until further notice.
TSX:ACB
by Raw_Blitz
7
WEED - Technical AnalysisDear Traders, Let's have a look at WEED (Canopy), since it reached it's new ATH, WEED has been retracing back to the 55 ema (Which is a common thing). But the question was, will that 55 ema hold, well for now it does, but this week has been very volatile. As long as we stay above that 55 ema, we are in a bullish mood/trend. If we succeed in staying above the 55 ema, our next target will be the 0.5 fib level that serves as a huge resistance for WEED. Bulls have tried multiple times to breach it but without success. And until that 0.5 fib level hasn't fallen, we won't see any run soon. Any thoughts ?
TSX:WEED
by Raw_Blitz
AUXLY - Techincal AnalysisDear Traders, After a 116% run, AUXLY is arming it self for a new breakout. Price action is above the 55,100 and 200 ema on the hourly Chart, which is bullish. The MACD just crossed downwards, which should be bearish, we will know soon. If AUXLY's price manages to stay above those EMA's, I would enter a trade. That 200 ema looks like a perfect entry point. A breakout above 1.25 would confirm that this is a bullish trend. BUT that 200 ema must hold. About Auxly Cannabis Group Inc. Cannabis Wheaton Income Corp is an investment and merchant company. It seeks to provide investor returns through streams and capital appreciation in the cannabis industry of Canada.
X
by Raw_Blitz
2
LHS - Technical AnalysisDear Traders, After a whopping 170% run, Liberty Health Sciences (LHSIF), Has started it's retracement, and in my opinion, it's not done retracing just yet. If you look at the green circle you'll find a perfect entry. a bounce off of the 0.50fib level where the 55 ema and the 200 ema is located. If a bounce off takes place, there is also a chance that the 55 ema crosses the 200 ema which would be very bullish in our case. What are your thoughts? NEWS: technical420.com About Liberty Health Sciences Inc: Liberty Health Sciences Inc. manufactures and distributes medical cannabis. The Company cultivates and markets pharmaceutical grade marijuana. Liberty Health Sciences markets its products in the United States and Canada.
L
by Raw_Blitz
2
TILRAY - Tecnical AnalysisDear Traders, After TILRAY's crazy 92% run, it was time for it to retrace, and it did. Now that TILRAY has found support at the 0.382 fib level, we need to think. There are 2 possibilities here, or we retrace down to the 200 ema (which would be logic), or we have found enough support at this fib level to start building up again. I drew a green line marking a resistance line, and TLRY needs to breakout of it before turning bullish again. A good entry would be the 200 ema on the 1hr chart. What are your thoughts ?
NASDAQ:TLRY
by Raw_Blitz
GTEC - 200 ema entry point?Dear Traders, A little update on the GTEC stock. Our MACD shows us a Bullish Continuing Divergence, which is a bullish sign. This combined with the 200 ema being close, I'm expecting a bounce off from that 200 ema located at 1.08$. This might be a very good entry point in my opinion, but, if you are entering I would choose your stoploss carefully. I'm saying this because on a GTEC Bullboard, i saw some negative messages coming by such as : ''recent press release said they lost an expansion because the city voted no. also they just applied for an alberta sales license, I work for the AGLC, this process takes 4 months.'' People are saying it's price will drop under 1$ blablabla... This could be to create FUD, so that they can buy cheaper. I'm only relying on TA. Fud is something you come across on each forum about a stock unfortunately.. I didnt find any official press release backing up the negativity this person said on the bullboard so let's see how this plays off.
G
by Raw_Blitz
Aurora Cannabis Inc - New All Times High Incoming !Dear Traders, Aurora Cannabis Appears Headed to the New York Stock Exchange! This news came out yesterday just before the closing of the market. And as we can see ACB's price broke out like we hoped it would, this is the kind of news we needed to get to a new ATH. Read more about the news here: www.newcannabisventures.com Another thing to keep in mind is that Aurora Cannabis Inc. owns 21% of TGOD, so I'm pretty sure TGOD will get benefits from this news. Aurora can still buy up to 51% of TGOD, and this will eventually happen. Let's see how far Aurora will go on Monday! I'll keep you up to date.
TSX:ACBLong
by Raw_Blitz
6
APHRIA - Technical AnalysisDear Traders, Today I'm having a look at APH, As we can see we had a retracement going on for a week, and it's price now hit the 200 EMA on the 4H chart. this happened before and it created a nice bounce. The question is, will this support level hold again? My guess? Yes. Look at that continuing BUllish divergence in the MACD, this shows us something will happen soon, and it's bullish. Perfect entry point would be the 200 ema. APHRIA NEWS: Aphria To Announce First Quarter Results On October 12, 2018 => Keep on eye on the charts that day, good news could bring more vol. - Source: web.tmxmoney.com ABOUT APH: Aphria Inc is licensed to produce and sell medical marijuana, including dried cannabis and cannabis oil, as a Licensed Producer under the provisions of the ACMPR.
ALong
by Raw_Blitz
ICNAF - Growing Vol ? New breakout ?Dear Traders, ICNA had a new run and retraced a little bit before finding support at the 55 ema (which was expected). I traced a red support line and a green resistance line which will help us figure out when a breakout upwards or downwards will occur. Right now our price as bounced off the 55 ema, with a volume that is building up, this could mean we will see a rise in the price this Monday. If the bulls buy the resistance at the 0.386 fib level we might get another run which will, in my opinion, create a lower high. The 0.5 fib level might stop our run, but with enough momentum and vol we could break through it. Let's see what happens on Monday. Latest news: globenewswire.com ''Integrated Cannabis is pleased to announce the successful completion and positive results of a controlled trial of its proprietary Sleep product.''
ILong
by Raw_Blitz
TRULIEVE - Technical AnalysisDear Traders, We don't have enough data to predict what so ever, for now, the only thing we can do is draw the lines and see how this will evolve over time. There is a lot of hype around this stock so anything could happen. About Trulieve Cannabis Corp (TCNNF) : Trulieve Cannabis Corp. operates as a holding company. The Company, through its subsidiaries, engages in the cultivation, possession, sale, and distribution of medical cannabis. Trulieve Cannabis offers its services in the United States and Canada.
OTC:TCNNF
by Raw_Blitz
4
TILRAY - Technical AnalysisDear Traders, We can see that TLRY has broken out but without big volume (which I expect, to be honest). I think most Traders/Bots are waiting for the MACD to cross upwards signal before creating another run-up. Let's see how this plays out. If you enter, don't forget your stop loss. About TILRAY: Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. Its products include dried cannabis and cannabis extracts. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada. Latest news: www.fool.com
NASDAQ:TLRYLong
by Raw_Blitz
Kalytera - Technical AnalysisDear Traders, As we can see KALY is retracing, the idea is to find our next entry point. Have a look at the green circle, that 50 fib level might be our point of interest. About Kalytera Therapeutics Kalytera Therapeutics, Inc. ("Kalytera") is pioneering the development of a next generation of cannabinoid therapeutics. Through its proven leadership, drug development expertise, and intellectual property portfolio, Kalytera seeks to establish a leading position in the development of novel cannabinoid medicines for a range of important unmet medical needs, with an initial focus on graft versus host disease (“GVHD”) . Kalytera also intends to develop a new class of proprietary cannabidiol ("CBD") therapeutics. CBD is a versatile compound that has shown activity against a number of pharmacological targets. However, there are limitations associated with natural CBD, including its poor oral bioavailability. Kalytera will seek to develop innovative CBD formulations and prodrugs in an effort to overcome these limitations, and to target specific disease sites within the body. Kalytera intends to file composition of matter and method of use patents covering its novel inventions, with the goal of limiting future competition. Website Home: kalytera.co News and Insights: kalytera.co Investors: kalytera.co
K
by Raw_Blitz
ABBVIE - Technical AnalysisDear Traders, ABBVIE looks to be on the edge for a breakout, the MACD shows a Bullish Hidden Divergence which backs-up my LONG position. Any thoughts ? About Abbvie: AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the discovery, development, manufacture and sale of a line of proprietary pharmaceutical products. It is focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.
NYSE:ABBVLong
by Raw_Blitz
GWPH - Technical AnalysisDear Traders, GWPH, also known as GGW Pharmaceuticals plc (GWPH), has been following its bullish Channel pretty well. Thos I don't really know if im Bullish or Berish for now. We have good volume, we are in a bullish channel, but we are under the 1H 55 ema (Blue line). If resistance at the 55 ema holds, we will see a bit more retracing, but if we succeed in buying that resistance, i'll be 100% bullish. About GWPH : GW Pharmaceuticals plc researches and develops cannabinoid prescription medicines for the treatment of cancer pain, Multiple Sclerosis, and neuropathic pain. Latest News: finance.yahoo.com
G
by Raw_Blitz
GTEC - Technical AnalysisDear Traders, As we can clearly see, GTEC's price is in a bullish channel. With a Hidden DIvergence in the MACD, it could be possible we will soon see a run-up. This Hypothosys would be cancelled if we break downwards from the channel. Last News: Update on Status of Sales License and Other Operational Updates: GTEC Provides Update on Status of Sales License and Other Operational Updates GTEC Holdings Ltd. (GTEC.V) (GGTTF) (“GTEC” or the “Company“) is pleased to provide an update on the operations of its wholly owned subsidiaries. Alberta Craft Cannabis Inc. (“ACC”) is a Licensed Producer under Health Canada’s Access to Cannabis for Medical Purposes Regulations located in Edmonton , Alberta. ACC operates a 14,000 sq. ft. craft cannabis cultivation facility. ACC has currently completed its initial harvests and has notified Health Canada. The Company is now awaiting Sales License inspection to be completed within the expected timeline. F-20 Joint Venture (“F-20”) is a GTEC agreement with F-20 Developments Corp. to develop a premium indoor cultivation facility in Vernon, British Columbia . GTEC’s operations team has completed the final design of Phase 1 construction plans. The building will be retrofitted to facilitate the cultivation of premium cannabis. Phase 1 of this partnership is currently underway, with completion anticipated for Q2 2019. GTEC expects to complete Phase 2 designs by Q1 of 2019. Tumbleweed Farms Corp. (“Tumbleweed”) is a late stage ACMPR applicant based in Chase, British Columbia . Tumbleweed has completed its purpose-built exterior and is near completion of the interior construction. The Company anticipates that it will commence cultivation over the duration of the fall season. Tumbleweed has also signed a contract with the Pacific Agricultural Certification Society (“PACS”) with an objective to be one of the first certified organic cannabis companies in Canada . GreenTec Bio-Pharmaceuticals Inc. (“GreenTec”) is a late stage ACMPR applicant based in Kelowna, British Columbia . GreenTec is currently in Phase 1 of development, building 20,000 sq. ft. of its planned 80,000 sq. ft. craft cannabis cultivation facility. GreenTec has recently completed the exterior of this building and anticipates completing the interior construction and commencing cultivation in Q1 2019. Grey Bruce Farms Inc. (“Grey Bruce”) is a late stage ACMPR applicant based in Kincardine, Ontario . Grey Bruce is currently building a 15,000 sq. ft. craft cannabis cultivation facility. The Company has made substantial progress in completing a major retrofit of its existing industrial building and anticipates that it will commence cultivation in Q4 2018. Falcon Ridge Naturals (“Falcon Ridge”) is a late stage ACMPR applicant located on a certified organic farm in Kelowna, British Columbia . Falcon Ridge was seeking to construct a 10,000 sq. ft. facility. On October 1st , Kelowna City Council voted against the Falcon Ridge project application, due to recently adopted land zoning issues related to the proposed facility being within the B.C. Agricultural Land Reserve. Accordingly, GTEC does not anticipate moving forward with this project, and plans to re-allocate Falcon Ridge capital funds to its larger facilities and/or for existing expansion opportunities. Spectre Labs Inc. (“Spectre”) is a cannabis oil extraction facility based in Kelowna , British Columbia. Spectre has acquired land and building to develop a state-of-the-art facility. The Company has completed initial design work and submitted an application to the Office of Controlled Substances for a Dealer’s License. The site will be developed in a phased approach and will serve as a Good Manufacturing Practices (“GMP”) grade facility with extraction, formulation, compounding and export capabilities to support GTEC’s Licensed Producers and the global medical market. GTEC also intends to utilize Spectre to manufacture edible products that are expected to be incorporated into Health Canada’s regulatory framework in 2019. GTEC was notified on July 17 th by the Office of Controlled Substances, that Spectre has been assigned an application number. From the time of receipt of a complete application, the Controlled Drugs Section commits to a service delivery standard of 180 business days for the issuance of a decision on an application for a new Dealer’s Licence for controlled substances.
GLong
by Raw_Blitz